Published in Int J Tuberc Lung Dis on June 01, 2005
Gender difference in knowledge of tuberculosis and associated health-care seeking behaviors: a cross-sectional study in a rural area of China. BMC Public Health (2008) 1.88
Factors associated with patient and health care system delay in diagnosis for tuberculosis in the province of Luanda, Angola. BMC Infect Dis (2013) 1.11
Barriers and delays in tuberculosis diagnosis and treatment services: does gender matter? Tuberc Res Treat (2014) 0.85
Association between South African high-school learners' knowledge about tuberculosis and their intention to seek healthcare. Glob Health Action (2013) 0.85
The role of gender and literacy in the diagnosis and treatment of tuberculosis. Int J Tuberc Lung Dis (2005) 0.80
Delayed treatment of diagnosed pulmonary tuberculosis in Taiwan. BMC Public Health (2008) 0.75
Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology (2000) 3.42
A urease-negative mutant of Helicobacter pylori constructed by allelic exchange mutagenesis lacks the ability to colonize the nude mouse stomach. Infect Immun (1994) 2.94
Endoscopic resection of early gastric cancer. Endoscopy (1993) 2.88
Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology (2001) 2.62
Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group. Hepatology (1998) 2.62
Establishment of a small animal model for human Helicobacter pylori infection using germ-free mouse. Am J Gastroenterol (1994) 2.00
Endoscopic therapy for early colon cancer: the strip biopsy resection technique. Gastrointest Endosc (1991) 1.86
Endoscopic ultrasonography and endoscopy for staging depth of invasion in early gastric cancer: a pilot study. Gastrointest Endosc (1997) 1.72
Morphologic studies of the liver cell dysplasia. Cancer (1983) 1.70
Hepatitis C virus RNA in saliva. Lancet (1990) 1.62
Endoscopic ultrasonography for diagnosis of submucosal invasion in early gastric cancer. J Gastroenterol (2000) 1.61
Epstein-Barr virus-associated gastric carcinoma and atrophic gastritis. J Clin Gastroenterol (1999) 1.59
New small animal model for human gastric Helicobacter pylori infection: success in both nude and euthymic mice. Am J Gastroenterol (1991) 1.55
Detection of K-ras and p53 gene mutations in pancreatic juice for the diagnosis of intraductal papillary mucinous tumors. Pancreas (1999) 1.54
Epstein-Barr virus infection of the colon with inflammatory bowel disease. Am J Gastroenterol (1999) 1.46
Urease plays an important role in the chemotactic motility of Helicobacter pylori in a viscous environment. Infect Immun (1998) 1.46
A blind comparison of the effectiveness of endoscopic ultrasonography and endoscopy in staging early gastric cancer. Gut (1999) 1.41
[Early gastric cancer staging by radiology, endoscopy, trans-endoscopic ultrasonography and its anatomo-pathological correlation]. G E N (1995) 1.40
Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: their relationship to clinicopathological features. Hepatology (1999) 1.37
Long-term follow-up of large flat colorectal tumors resected endoscopically. Endoscopy (2003) 1.33
Macrophages and dendritic cells infiltrating islets with or without beta cells produce tumour necrosis factor-alpha in patients with recent-onset type 1 diabetes. Diabetologia (2007) 1.30
Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy. Hepatology (1997) 1.30
MAIL, a novel nuclear I kappa B protein that potentiates LPS-induced IL-6 production. FEBS Lett (2000) 1.21
Epstein-Barr virus infection in non-carcinomatous gastric epithelium. J Pathol (1997) 1.20
Differences in hypervariable region 1 quasispecies of hepatitis C virus in human serum, peripheral blood mononuclear cells, and liver. Hepatology (1999) 1.19
In vitro anti-Helicobacter pylori activities of new rifamycin derivatives, KRM-1648 and KRM-1657. Antimicrob Agents Chemother (1999) 1.16
Predominance of β-cell neogenesis rather than replication in humans with an impaired glucose tolerance and newly diagnosed diabetes. J Clin Endocrinol Metab (2013) 1.15
Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer. Br J Cancer (2003) 1.13
Postoperative bile peritonitis caused by division of an aberrant bile duct in the left triangular ligament of the liver. Am J Gastroenterol (1996) 1.12
Continuous stimulation of human glucagon-like peptide-1 (7-36) amide in a mouse model (NOD) delays onset of autoimmune type 1 diabetes. Diabetologia (2007) 1.12
A fundamental study of normal layer structure of the gastrointestinal wall visualized by endoscopic ultrasonography. Scand J Gastroenterol Suppl (1986) 1.11
A comparison of DNA copy number changes detected by comparative genomic hybridization in malignancies of the liver, biliary tract and pancreas. Oncology (2001) 1.11
Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines. Cancer Lett (2000) 1.10
Epstein-Barr virus promotes epithelial cell growth in the absence of EBNA2 and LMP1 expression. J Virol (1999) 1.09
Percutaneous radiofrequency ablation therapy with combined angiography and computed tomography assistance for patients with hepatocellular carcinoma. Cancer (2001) 1.08
Augmenter of liver regeneration (ALR) may promote liver regeneration by reducing natural killer (NK) cell activity in human liver diseases. J Gastroenterol (2000) 1.07
Interferon treatment improves survival in chronic hepatitis C patients showing biochemical as well as virological responses by preventing liver-related death. J Viral Hepat (2004) 1.06
Essential role of Helicobacter pylori urease in gastric colonization: definite proof using a urease-negative mutant constructed by gene replacement. Eur J Gastroenterol Hepatol (1994) 1.06
Diagnostic utility of 20-megahertz linear endoscopic ultrasonography in early gastric cancer. Gastrointest Endosc (1996) 1.05
The pharmacokinetics and pharmacodynamics of tolvaptan in patients with liver cirrhosis with insufficient response to conventional diuretics: a multicentre, double-blind, parallel-group, phase III study. J Int Med Res (2012) 1.04
Cytochrome P-450 in hyperplastic liver nodules during hepatocarcinogenesis with N-2-fluorenylacetamide in rats. Gan (1976) 1.04
Localization of -fetoprotein in hepatoma tissues by immunofluorescence. Cancer Res (1972) 1.03
Endoscopic mucosal resection for early esophageal cancer and esophageal dysplasia. Hepatogastroenterology (2001) 1.00
Effectiveness of local endoscopic resection of rectal carcinoid tumors. Endoscopy (1997) 0.99
Examination of oncogene amplification by genomic DNA microarray in hepatocellular carcinomas: comparison with comparative genomic hybridization analysis. Cancer Genet Cytogenet (2001) 0.99
Endoscopic ultrasonography of superficial esophageal cancers using a thin ultrasound probe system equipped with switchable radial and linear scanning modes. Gastrointest Endosc (1996) 0.98
Endoscopic and pathologic features of Epstein-Barr virus-associated gastric carcinoma. Gastrointest Endosc (1997) 0.98
Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1alpha is dominant negative. Diabetes (1998) 0.97
Endoscopic diagnosis and resection treatment for flat adenoma with severe dysplasia. Am J Gastroenterol (1993) 0.96
Hepatitis C virus quasispecies and response to interferon therapy in patients with chronic hepatitis C: a prospective study. J Viral Hepat (2000) 0.95
A possible role of hypervariable region 1 quasispecies in escape of hepatitis C virus particles from neutralization. J Viral Hepat (2001) 0.95
Overproduction and purification of SulA fusion protein in Escherichia coli and its degradation by Lon protease in vitro. Appl Microbiol Biotechnol (1995) 0.95
Interferon gamma treatment prevents procollagen gene expression without affecting transforming growth factor-beta1 expression in pig serum-induced rat liver fibrosis in vivo. J Hepatol (1998) 0.94
Hepatocyte nuclear factor-4 alpha gene mutations in Japanese non-insulin dependent diabetes mellitus (NIDDM) patients. Res Commun Mol Pathol Pharmacol (1996) 0.93
The successive strip biopsy partial resection technique for large early gastric and colon cancers. Gastrointest Endosc (1992) 0.93
Enhanced interstitial collagenase (matrix metalloproteinase-13) production of Kupffer cell by gadolinium chloride prevents pig serum-induced rat liver fibrosis. Biochem Biophys Res Commun (2000) 0.93
Case report: hypoechoic submucosal nodules: a sign of Epstein-Barr virus-associated early gastric cancer. J Gastroenterol Hepatol (1998) 0.92
Growth medium containing cyclodextrin and low concentration of horse serum for cultivation of Helicobacter pylori. Microbiol Immunol (1994) 0.92
Injection sclerotherapy for gastric varices using N-butyl-2-cyanoacrylate and ethanolamine oleate. Hepatogastroenterology (1998) 0.90
Inhibitory effects of the herbal medicine Sho-saiko-to (TJ-9) on cell proliferation and procollagen gene expressions in cultured rat hepatic stellate cells. J Hepatol (1998) 0.90
Protection against acetaminophen-induced liver injury in vivo by an iron chelator, deferoxamine. Scand J Gastroenterol (1995) 0.90
Laparoscopic ultrasonography. Diagnosis of liver and pancreatic cancer. Scand J Gastroenterol Suppl (1984) 0.89
Esophageal hemangioma: endoscopic diagnosis and treatment. Endoscopy (1994) 0.89
Correlation between stellate cell activation and serum fibrosis markers in choline-deficient L-amino acid-defined diet-induced rat liver fibrosis. Dig Dis Sci (2000) 0.89
The prolyl 4-hydroxylase inhibitor HOE 077 prevents activation of Ito cells, reducing procollagen gene expression in rat liver fibrosis induced by choline-deficient L-amino acid-defined diet. Hepatology (1996) 0.89
Bleeding Meckel's diverticulum in an adult. Hepatogastroenterology (2002) 0.89
Herbal medicine Sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. J Hepatol (1998) 0.89
Anticachectic effects of Coptidis rhizoma, an anti-inflammatory herb, on esophageal cancer cells that produce interleukin 6. Cancer Lett (2000) 0.88
A new common marker for premalignant and malignant hepatocytes induced in the rat by chemical carcinogens. J Natl Cancer Inst (1975) 0.88
Glycine-to-arginine substitution at codon 145 of HBsAg in two infants born to hepatitis B e antigen-positive carrier. Dig Dis Sci (1995) 0.88
High prevalence of Epstein-Barr virus in gastric remnant carcinoma after Billroth-II reconstruction. Scand J Gastroenterol (2002) 0.88
99mTc-HSA-D scintigraphy in the diagnosis of protein-losing gastroenteropathy due to secondary amyloidosis. J Gastroenterol (1997) 0.88
The effect of verbal feedback on motor learning--a PET study. Positron emission tomography. Neuroimage (2000) 0.88
Abducent nerve paralysis during interferon alpha-2a therapy in a case of chronic active hepatitis C. Intern Med (1994) 0.88
Type I interferon receptor and response to interferon therapy in chronic hepatitis C patients: a prospective study. J Viral Hepat (2004) 0.87
Prevention of fibrosis reduces enzyme-altered lesions in the rat liver. Carcinogenesis (1994) 0.87
Metaplastic polyp of the colon develops in response to inflammation. J Gastroenterol Hepatol (1999) 0.87
Pancreatic beta and alpha cells are both decreased in patients with fulminant type 1 diabetes: a morphometrical assessment. Diabetologia (2005) 0.86
[Evaluation of MRCP compared to ERCP in the diagnosis of biliary and pancreatic duct]. Nihon Rinsho (1998) 0.86
Cytoprotection by glycine against hypoxia-induced injury in cultured hepatocytes. Liver (1997) 0.86
Localization of alpha-fetoprotein by immunofluorescence in hyperplastic nodules during hepatocarcinogenesis induced by 2-acetylaminofluorene. Cancer Res (1974) 0.86
Lipid composition and fatty acid analysis of Helicobacter pylori. J Gastroenterol (1995) 0.86
Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-alpha therapy. Dig Dis Sci (1995) 0.86
Efficacy of sucralfate in the prevention of recurrence of peptic ulcer--double blind multicenter study with cimetidine. Scand J Gastroenterol Suppl (1987) 0.86
Therapeutic results of endoscopic variceal ligation for acute bleeding of oesophageal and gastric varices. J Gastroenterol Hepatol (1997) 0.86
Inhibition of tumor necrosis factor-alpha production retards liver regeneration after partial hepatectomy in rats. Biochem Biophys Res Commun (1997) 0.86
Dissociation between muscle metabolism and oxygen kinetics during recovery from exercise in patients with chronic heart failure. Heart (2000) 0.85
Endoscopic management of gastric varices using a detachable snare and simultaneous endoscopic sclerotherapy and O-ring ligation. J Gastroenterol Hepatol (1999) 0.85
Multislice dynamic MRI of hepatic tumors. J Comput Assist Tomogr (1993) 0.84
Choledochoduodenal fistula: a complication of a penetrated duodenal ulcer. Hepatogastroenterology (1997) 0.84
Evaluation of new therapy for eradication of H. pylori infection in nude mouse model. Am J Gastroenterol (1993) 0.84
[A case of ischemic enteritis showing a tubular stenosis]. Nihon Shokakibyo Gakkai Zasshi (2000) 0.84
Prolyl 4-hydroxylase inhibitor (HOE 077) prevents TIMP-1 gene expression in rat liver fibrosis. J Gastroenterol (1999) 0.84
Expression of hepatocyte growth factor, transforming growth factor alpha, and transforming growth factor beta 1 messenger RNA in various human liver diseases and correlation with hepatocyte proliferation. Hepatology (1996) 0.84
Hepatocyte proliferation induced in rats by lead nitrate is suppressed by several tumor necrosis factor alpha inhibitors. Hepatology (1996) 0.84
Iron chelator deferoxamine reduces preneoplastic lesions in liver induced by choline-deficient L-amino acid-defined diet in rats. Dig Dis Sci (1999) 0.84
Saikosaponin A-induced cell death of a human hepatoma cell line (HuH-7): the significance of the 'sub-G1 peak' in a DNA histogram. Pathol Int (1995) 0.84
Endoscopic ultrasonography. Clin Gastroenterol (1986) 0.83